Day One Biopharmaceuticals, Inc. (DAWN) Share-based Payment Arrangement, Expense USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Day One Biopharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
  • Day One Biopharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $12.6 M, a 33.8% increase year-over-year.
  • Day One Biopharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $42.5 M, a 39.5% increase year-over-year.
  • Day One Biopharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $39.3 M, a 44.4% increase from 2022.
  • Day One Biopharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $27.2 M, a 105% increase from 2021.
  • Day One Biopharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $13.3 M, a 2433% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $42.5 M $12.6 M +$3.2 M +33.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $39.3 M $10.8 M +$3.98 M +58.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $35.4 M $9.61 M +$1.03 M +12% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $34.3 M $9.48 M +$3.85 M +68.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $30.5 M $9.45 M +$3.25 M +52.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $27.2 M $6.83 M +$1.74 M +34.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $25.5 M $8.58 M +$3.43 M +66.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $22.1 M $5.63 M +$3.09 M +122% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $19 M $6.2 M +$5.66 M +1053% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-01
Q4 2021 $13.3 M $5.1 M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $5.15 M +$5.09 M +8482% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $2.54 M +$2.48 M +4351% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $538 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $60 K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $57 K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.